1. Home
  2. |Insights
  3. |Transportation Leaders Propose Massive Public-Private Partnership Project in Northeast Rail Corridor

Transportation Leaders Propose Massive Public-Private Partnership Project in Northeast Rail Corridor

Client Alert | less than 1 min read | 05.27.11

On May 26, 2011, House Transportation leaders outlined a dramatic Public-Private Partnership proposal designed to bolster the development of high-speed rail in the heavily populated "Northeast Corridor." Continuing the trend towards PPP procurement on the federal, state and local levels, the proposed legislation would separate the Northeast Corridor from Amtrak, transfer it to a separate entity, and begin a competitive bidding process that would allow for a PPP to design, build, operate, maintain, and finance high-speed rail service over the next 10 years.

Insights

Client Alert | 7 min read | 09.14.26

AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development

Over the past several years, the biopharmaceutical industry has embraced artificial intelligence and machine learning (AI/ML) in near lockstep with the pace of AI/ML innovations. Today, industry leaders are using AI/ML to, among other things: discover and assess biological pathways, target chemical structures and sequences; design proteins; model pre-clinical and clinical trials; recruit and screen potential patient populations; evaluate clinical trial results and biomarker data; prepare regulatory filings; and manage supply chains. Deployment of new AI/ML models promises extraordinary advances in pharmaceutical development. However, as with any technological and scientific advances, the use of AI/ML also poses substantial legal risks that life sciences companies need to consider and proactively manage. ...